Wyeth Pharmaceuticals

Huntercombe Lane South, Taplow, Maidenhead, Berks, SL6 0PH
Telephone: +44 (0)1628 604 377
Fax: +44 (0)1628 666 368
Medical Information e-mail: EUMEDINFO@Pfizer.com

Patient Information Leaflet last updated on the eMC: 22/10/2010
PIL InductOs 12mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/10/2010 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 20/04/2010 and displayed until 22/10/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to side-effects
Updated on 05/08/2008 and displayed until 20/04/2010
Reasons for adding or updating:
  • Change to Further Information section
Updated on 06/06/2008 and displayed until 05/08/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 23/05/2007 and displayed until 06/06/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to Further Information section
  • Change to date of revision
Updated on 29/09/2006 and displayed until 23/05/2007
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 18/09/2006 and displayed until 29/09/2006
Reasons for adding or updating:
  • Change to side-effects
  • Change to Further Information section
Updated on 21/06/2005 and displayed until 18/09/2006
Reasons for adding or updating:
  • Change of manufacturer
Updated on 09/05/2005 and displayed until 21/06/2005
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
  • Change to storage instructions
Updated on 22/12/2004 and displayed until 09/05/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 12/09/2003 and displayed until 22/12/2004
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   dibotermin alfa